EUVIMEDEUVIMED entdecken
Crossref

Pharmacogenetic insights into SLC22A1 and SLC22A2 polymorphisms affecting glycemic response to oral hypoglycemic agents

Ipseeta Ray Mohanty, Shouvik Ganguly, Sandeep Rai

International Journal of Diabetes in Developing Countries · 28.04.2026

DOI: 10.1007/s13410-026-01666-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Diabetes in Developing Countries, online erschienen am 28.04.2026. Verfasst von Ipseeta Ray Mohanty und 2 weiteren Autor:innen. Die Arbeit nennt 21 Literaturangaben. Gefördert von: Indian Council of Medical Research.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Förderung

  • Indian Council of Medical Research

Zitieren

APA

Mohanty, I. R., Ganguly, S., & Rai, S. (2026). Pharmacogenetic insights into SLC22A1 and SLC22A2 polymorphisms affecting glycemic response to oral hypoglycemic agents. International Journal of Diabetes in Developing Countries. https://doi.org/10.1007/s13410-026-01666-3

Vancouver

Mohanty IR, Ganguly S, Rai S. Pharmacogenetic insights into SLC22A1 and SLC22A2 polymorphisms affecting glycemic response to oral hypoglycemic agents. International Journal of Diabetes in Developing Countries. 2026. doi:10.1007/s13410-026-01666-3

BibTeX
@article{Mohanty2026,
  author = {Mohanty, Ipseeta Ray and Ganguly, Shouvik and Rai, Sandeep},
  title = {Pharmacogenetic insights into SLC22A1 and SLC22A2 polymorphisms affecting glycemic response to oral hypoglycemic agents},
  journal = {International Journal of Diabetes in Developing Countries},
  year = {2026},
  doi = {10.1007/s13410-026-01666-3}
}
Kostenlos starten →